Reply

Affiliations

¹ Dobney Hypertension Centre, University of Western Australia - Royal Perth Hospital Campus, Perth, Western Australia, Australia.
² Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy.
³ Division of Cardiovascular Sciences, Faculty of Medicine, Biology and Health, University of Manchester, Manchester, UK.
⁴ Third Department of Medicine, Hypertension Center STRIDE-7, School of Medicine, Sotiria Hospital, National and Kapodistrian University of Athens, Athens, Greece.
⁵ Faculty of Medicine, University of New South Wales, The George Institute for Global Health, Sydney, New South Wales, Australia.
⁶ CARIM - School for Cardiovascular Diseases, Maastricht University, Maastricht, The Netherlands.

Comment

Markus P Schlaich et al. J Hypertens. 2020 Nov.

. 2020 Nov;38(11):2339-2340.

doi: 10.1097/HJH.0000000000002612.

¹ Dobney Hypertension Centre, University of Western Australia - Royal Perth Hospital Campus, Perth, Western Australia, Australia.
² Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy.
³ Division of Cardiovascular Sciences, Faculty of Medicine, Biology and Health, University of Manchester, Manchester, UK.
⁴ Third Department of Medicine, Hypertension Center STRIDE-7, School of Medicine, Sotiria Hospital, National and Kapodistrian University of Athens, Athens, Greece.
⁵ Faculty of Medicine, University of New South Wales, The George Institute for Global Health, Sydney, New South Wales, Australia.
⁶ CARIM - School for Cardiovascular Diseases, Maastricht University, Maastricht, The Netherlands.

No abstract available

Comment on

2020 International Society of Hypertension global hypertension practice guidelines.
Unger T, Borghi C, Charchar F, Khan NA, Poulter NR, Prabhakaran D, Ramirez A, Schlaich M, Stergiou GS, Tomaszewski M, Wainford RD, Williams B, Schutte AE. Unger T, et al. J Hypertens. 2020 Jun;38(6):982-1004. doi: 10.1097/HJH.0000000000002453. J Hypertens. 2020. PMID: 32371787 No abstract available.
Blind spots in the new International Society of Hypertension guidelines: physiologically individualized therapy for resistant hypertension based on renin/aldosterone phenotyping, and amiloride for Liddle phenotype.
Spence JD. Spence JD. J Hypertens. 2020 Nov;38(11):2338. doi: 10.1097/HJH.0000000000002611. J Hypertens. 2020. PMID: 33027115 No abstract available.

1. Spence JD. Blind spots in the new International Society of Hypertension guidelines: physiologically individualized therapy for resistant hypertension based on renin/aldosterone phenotyping, and amiloride for Liddle phenotype. J Hypertens 2020; 38:???–???.
1. Unger T, Borghi C, Charchar F, Khan NA, Poulter NR, Prabhakaran D, et al. 2020 International Society of Hypertension global hypertension practice guidelines. J Hypertens 2020; 38:982–1004.
1. Liddle GW, Bledsoe T, Coppage WS Jr. A familial renal disorder simulating primary aldosteronism but with negligible aldosterone secretion. Trans Assoc Am Phys 1963; 76:199–213.
1. Warnock DG. Liddle syndrome: genetics and mechanisms of Na+ channel defects. Am J Med Sci 2001; 322:302–307.
1. Botero-Velez M, Curtis JJ, Warnock DG. Brief report: Liddle's syndrome revisited – a disorder of sodium reabsorption in the distal tubule. N Engl J Med 1994; 330:178–181.